The training, which will take place from 9 to 18 November in virtual format, will equip biosanitary professionals with the international standards governing clinical trials The Marqués de Valdecilla Research Institute (IDIVAL) will hold the seventh edition of the Good Clinical Practice ICH E6 (R3) Course from 9 to 18 November 2026, a training initiative […]
The study, published in the Journal of Neuro-Oncology, demonstrates the potential of this technology to complement intraoperative identification of tumor margins without using external markers. A team of researchers affiliated with IDIVAL, the Marqués de Valdecilla University Hospital, and the University of Cantabria has shown that a nanoplasmonic biosensor is capable of distinguishing tumor tissue […]
The General Assembly of the Joint Action PreventNCD (JA PreventNCD) was held in Rome, attended on behalf of the Marqués de Valdecilla Health Research Institute (IDIVAL) and the Health Department of the Government of Cantabria by Ana P. Medina, Blanca Benito, María Zúñiga, and Carlos Fernández Viadero. During the meeting, participants reviewed the project’s progress […]
Documentation for the three funding schemes, together with supporting templates for preparing applications, is now available for consultation. The Spanish Foundation for Science and Technology (FECYT) has launched its 2026 calls for proposals to promote scientific culture and innovation. These calls aim to support initiatives that bring science closer to society, strengthen scientific advice for […]
Cantabria took part in the international ECTOH (European Conference on Tobacco or Health), held in Milan, with the oral presentation “Exposure to second-hand tobacco smoke in households in Cantabria: the influence of minors on indoor smoking behaviours.” The abstract, selected by the conference’s scientific committee for oral communication format, was presented by Ana P. Medina […]
The Nursing Research Group contributes to shaping the sustainability strategy for the European pilot projects on self-management of cardiovascular diseases and diabetes. The Marqués de Valdecilla Health Research Institute (IDIVAL), through its Nursing Research Group, co-leader of Work Package 10 (WP10) of the European JACARDI project, participated in the third Learning Session held in Mérida […]
Researchers from the Translational Hematopathology Research Group at the Marqués de Valdecilla Research Institute (IDIVAL) have demonstrated the value of a genetic alteration in the molecular classification of diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma in adults. The findings, published in Virchows Archiv, show that the MYD88L265P mutation is strongly […]
The Health Research Institute Valdecilla (IDIVAL) participated in the third consortium meeting of the European project CIRCE-JA, held on 25–26 May 2026 in Rome at the headquarters of AGENAS (Agenzia Nazionale per i Servizi Sanitari Regionali). The meeting brought together the organisations participating in the Joint Action to review the project’s progress, share the status […]
Doctors Eduardo Miñambres, from Marqués de Valdecilla University Hospital, and Mario Royo-Villanova, from Virgen de la Arrixaca University Hospital in Murcia, lead the study “Clinical Evidence of the Absence of Brain Perfusion During Thoraco-Abdominal Normothermic Regional Perfusion in Donation After Circulatory Determination of Death”, recently published in the scientific journal American Journal of Transplantation. The […]
The Magdalena Peninsula will host, on July 6 and 7, a conference organized by the Government of Cantabria in collaboration with IDIVAL, addressing the challenges of the digital transformation of the healthcare system The Magdalena Peninsula will be the venue on July 6 and 7 for the conference “Value‑Based Digital Health: Data and Precision Management […]
